Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T

Luigi Leanza1, Cristina Miazzi, Paola Ferraro

  • 1Department of Biology, University of Padova, Padova, Italy.

Insights

Guanine analogs, guanine-ß-d-arabinofuranoside (araG) and deoxyguanosine (GdR), exhibit T lymphocyte toxicity by interfering with DNA replication and inducing apoptosis. Their phosphorylation and cellular distribution influence toxicity, impacting DNA synthesis and cell cycle progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Deoxyguanosine (GdR) and its analog guanine-ß-d-arabinofuranoside (araG) demonstrate specific toxicity towards T lymphocytes.
  • This toxicity is linked to purine nucleoside phosphorylase (PNP) activity and requires intracellular phosphorylation to triphosphate forms, implicating DNA replication.
  • Understanding the mechanisms of these nucleoside analogs is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the mechanism of toxicity of guanine-ß-d-arabinofuranoside (araG) and deoxyguanosine (GdR) in T lymphocytes.
  • To investigate the role of intracellular phosphorylation and subcellular localization in nucleoside analog-induced cytotoxicity.
  • To determine the impact of these nucleosides on DNA synthesis, cell cycle progression, and apoptosis.

Main Methods:

  • Isotope-labeled araG and flow cytometry were used to track araG phosphate accumulation and turnover in cultured cells.
  • Kinetic analysis of cytosolic and mitochondrial kinases and deoxynucleotidases was performed.
  • Effects on dNTP pools, ribonucleotide reductase activity, DNA synthesis, cell cycle, and apoptosis were assessed.

Main Results:

  • araG phosphates rapidly accumulate and turn over, with distribution between cytosol and mitochondria influenced by kinase kinetics, leading to higher mitochondrial araGTP.
  • Deoxyguanosine triphosphate (dGTP) imbalances disrupt ribonucleotide reduction, inhibit DNA synthesis, and cause G1-S cell cycle arrest.
  • araGTP does not affect ribonucleotide reduction, but araG incorporation into DNA halts DNA synthesis, arresting cells in S-phase and inducing apoptosis via caspases.

Conclusions:

  • Both GdR and araG induce T lymphocyte apoptosis through mechanisms involving DNA replication interference and cell cycle arrest.
  • Subcellular localization of phosphorylation significantly impacts araGTP levels and subsequent cytotoxicity.
  • While high araG concentrations primarily affect nuclear DNA synthesis, potential effects on mitochondrial DNA at lower concentrations warrant further investigation.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...